Recondo G - Search Results

1

Specificity of the phase I trial for cytotoxic drugs in oncology.

Armand JP, Klink-Alakl M, Recondo G, de Forni M. Armand JP, et al. Among authors: recondo g. Fundam Clin Pharmacol. 1990;4 Suppl 2:197s-204s. doi: 10.1111/j.1472-8206.1990.tb00079.x. Fundam Clin Pharmacol. 1990. PMID: 2093632 Review.

2

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.

de Forni M, Chabot GG, Armand JP, Fontana X, Recondo G, Domenge C, Carde P, Barbu M, Gouyette A. de Forni M, et al. Among authors: recondo g. Eur J Cancer. 1993;29A(7):983-8. doi: 10.1016/s0959-8049(05)80206-0. Eur J Cancer. 1993. PMID: 8499153 Clinical Trial.

3

Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.

Tellez-Bernal E, Belehradek M, Recondo G, Cvitkovic E, Leridant AM, Vericel R, Armand JP. Tellez-Bernal E, et al. Among authors: recondo g. Am J Clin Oncol. 1990 Oct;13(5):452-4. doi: 10.1097/00000421-199010000-00018. Am J Clin Oncol. 1990. PMID: 1699403

4

A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.

Tellez-Bernal E, Recondo G, Guillot T, Benhamed M, Domenge C, Izzo J, Cvitkovic E, Armand JP. Tellez-Bernal E, et al. Among authors: recondo g. Cancer. 1990 Aug 15;66(4):640-4. doi: 10.1002/1097-0142(19900815)66:4<640::aid-cncr2820660406>3.0.co;2-d. Cancer. 1990. PMID: 2386892

5

96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia.

Recondo G, Benhamed M, Cvitkovic E, Marandas P, Armand JP. Recondo G, et al. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1529-33. doi: 10.1016/0277-5379(89)90293-9. Eur J Cancer Clin Oncol. 1989. PMID: 2480245

6

Phase II study of mitozolomide (M & B 39,565) in head and neck cancer.

Herait P, Armand JP, Benahmed M, Domenge C, Fontana X, Recondo G, Cvitkovic E, Delgado FM. Herait P, et al. Among authors: recondo g. Med Oncol Tumor Pharmacother. 1989;6(4):267-9. doi: 10.1007/BF02985159. Med Oncol Tumor Pharmacother. 1989. PMID: 2615530

7

[Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction].

Bonnay M, Gouyette A, Chabot G, Recondo G, Armand JP. Bonnay M, et al. Among authors: recondo g. Bull Cancer. 1989;76(8):839-41. Bull Cancer. 1989. PMID: 2620109 French. No abstract available.

8

A new anticancer agent (LY186641) interferes with creatinine assay.

Bonnay MM, Recondo G, Gouyette AJ, Armand JP. Bonnay MM, et al. Among authors: recondo g. Cancer Chemother Pharmacol. 1989;23(2):119-20. doi: 10.1007/BF00273530. Cancer Chemother Pharmacol. 1989. PMID: 2910508

9

Flavonoids: a new class of anticancer agents? Preclinical and clinical data of flavone acetic acid.

Armand J, De Forni M, Recondo G, Cals L, Cvitkovic E, Munck J. Armand J, et al. Among authors: recondo g. Prog Clin Biol Res. 1988;280:235-41. Prog Clin Biol Res. 1988. PMID: 3051027 Review. No abstract available.

10

Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization.

de Forni M, Chabot GG, Armand JP, Gouyette A, Klink-Alak M, Recondo G. de Forni M, et al. Among authors: recondo g. Cancer Chemother Pharmacol. 1995;35(3):219-24. doi: 10.1007/BF00686551. Cancer Chemother Pharmacol. 1995. PMID: 7805180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters